SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Martin James Lawrence (Last) (First) (Middle) 105 CORPORATE PARK DRIVE (Street) WHITE PLAINS NY 10604 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol PAXAR CORP [ PXR ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) President, Bar Code Systems
	3. Date of Earliest Transaction (Month/Day/Year) 06/15/2007
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/15/2007		D		14,097	D	(1)	0	D
Common Stock	06/15/2007		D		63,359	D	(2)	0	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$16.125	06/15/2007		D			18,504	(3)	01/31/2012	Common Stock	18,504	(3)	0	D
Stock Option (Right to Buy)	$14.575	06/15/2007		D			5,000	(4)	01/30/2013	0Common Stock	5,000	(4)	0	D
Stock Option (Right to Buy)	$14.135	06/15/2007		D			7,016	(5)	01/21/2014	Common Stock	7,016	(5)	0	D
Stock Option (Right to Buy)	$14.135	06/15/2007		D			2,984	(6)	01/21/2014	Common Stock	2,984	(6)	0	D
Stock Option (Right to Buy)	$17.91	06/15/2007		D			25,000	(7)	06/06/2015	Common Stock	25,000	(7)	0	D
Stock Option (Right to Buy)	$20.35	06/15/2007		D			12,100	(8)	01/26/2016	Common Stock	12,100	(8)	0	D
Stock Option (Right to Buy)	$22.02	06/15/2007		D			12,503	(9)	01/25/2017	Common Stock	12,503	(9)	0	D

Explanation of Responses:

1. Pursuant to a merger agreement between the issuer and Avery Dennison Corporation, these shares were disposed of by the registering person for $30.50 per share at the effective time of the merger.

2. Pursuant to a merger agreement between the issuer and Avery Dennison Corporation, these shares were disposed of by the registering person's spouse for $30.50 per share at the effective time of the merger.

3. The reporting person was granted options to purchase 18,504 shares of common stock on 1/31/2002, which became exercisable in four equal annual installments beginning on 1/31/2003. The unexcerised portion of these options were cancelled in the merger in exchange for options to purchase shares of Avery Dennison's common stock, representing the product of 18,504 shares of common stock and $30.50 divided by the average Avery Dennison stock price of $64.189 over the 20 days immediately prior to the merger.

4. The reporting person was granted options to purchase 5,762 shares of common stock on 1/30/2003, which became exercisable in four equal annual installments beginning on 1/30/2004. The unexcerised portion of these options were cancelled in the merger in exchange for options to purchase shares of Avery Dennison's common stock, representing the product of 5,000 shares of common stock and $30.50 divided by the average Avery Dennison stock price of $64.189 over the 20 days immediately prior to the merger.

5. The reporting person was granted options to purchase 7,016 shares of common stock on 1/21/2004, which became exercisable in four equal annual installments beginning on 1/21/2014. The unexcerised portion of these options were cancelled in the merger in exchange for options to purchase shares of Avery Dennison's common stock, representing the product of 7,016 shares of common stock and $30.50 divided by the average Avery Dennison stock price of $64.819 over the 20 days immediately prior to the merger.

6. The reporting person was granted options to purchase 12,984 shares of common stock on 1/21/2004, which became exercisable in four equal annual installments begining on 1/21/2005. The unexcerised portion of these options were cancelled in the merger in exchange for options to purchase shares of Avery Dennison's common stock, representing the product of 2,984 shares of common stock and $30.50 divided by the average Avery Dennison stock price of $64.189 over the 20 days immediately prior to the merger.

7. The reporting person was granted options to purchase 25,000 shares of common stock on 6/6/2005, which became exercisable in four equal annual installments beginning on 6/6/2006. The unexcerised portion of these options were cancelled in the merger in exchange for options to purchase shares of Avery Dennison's common stock, representing the product of 25,000 shares of common stock and $30.50 divided by the average Avery Dennison stock price of $64.189 over the 20 days immediately prior to the merger.

8. The reporting person was granted options to purchase 12,100 shares of common stock on 1/26/2006, which became exercisable in four equal annual installments beginning on 1/26/2007. The unexcerised portion of these options were cancelled in the merger in exchange for options to purchase shares of Avery Dennison's common stock, representing the product of 25,000 shares of common stock and $30.50 divided by the average Avery Dennison stock price of $64.819 over the 20 days immediately prior to the merger.

9. The reporting person was granted options to purchase 12,503 shares of common stock on 1/25/2006, which became exercisable in four equal annual installments beginning on 1/25/2007. The unexcerised portion of these options were cancelled in the merger in exchange for options to purchase shares of Avery Dennison's common stock, representing the product of 12,503 shares of common stock and $30.50 divided by the average Avery Dennison stock price of $64.189 over the 20 days immediately prior to the merger.

Remarks:

	/s/ Robert S. Stone, Attorney-in-Fact	06/19/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.